| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
VASCULAR BIOLOGY
- and TNF-
-induced ECAM expression and adhesion
Department of Chemical Engineering, Ohio University, Athens, Ohio 45701
Submitted 17 March 2003 ; accepted in final form 2 June 2003
A promising approach for reducing aberrant leukocyte-endothelial adhesion
during pathological inflammation is to inhibit endothelial cell adhesion
molecule (ECAM) expression at the transcription level. Several compounds have
been shown to decrease cytokine-induced upregulation of ECAMs primarily by
modulating the activity of transcription factors [e.g., nuclear
factor-
B (NF-B)]. The majority of the in vitro studies have
focused on the effect of transcription inhibitors on endothelial cells exposed
to a single cytokine [primarily tumor necrosis factor-
(TNF-)]
for a relatively short period of time (primarily 4-6 h). However, in the in
vivo setting, multiple cytokines [e.g., interleukin-1
(IL-1) and
TNF-] may be present for extended periods of time. Thus we studied the
effects of a transcription inhibitor, the proteasome inhibitor lactacystin, on
ECAM expression and myeloid (HL60) cell adhesion to human umbilical vein
endothelial cells (HUVEC) activated by concurrent, sequential, and long-term
(24 h) treatment with IL-1 and TNF-. We show, for the first time,
that lactacystin inhibits 1) 4-h concurrent IL-1- and
TNF--induced expression of E-selectin, VCAM-1, ICAM-1, and HL60 cell
adhesion to HUVEC; 2) 4-h TNF--induced expression of
E-selectin, VCAM-1, and HL60 cell adhesion to HUVEC that have become
desensitized to IL-1 activation; 3) 24-h TNF--induced
expression of E-selectin and VCAM-1 but not ICAM-1; and 4) 24-h
TNF--induced HL60 cell adhesion to HUVEC. Combined, our results
demonstrate that a proteasome inhibitor can reduce concurrent, sequential, and
long-term IL-1- and TNF--induced ECAM expression and myeloid cell
adhesion.
endothelial cell adhesion molecules; inflammation; cytokines; proteasome inhibitor
This article has been cited by other articles:
|
|
 |
|
  D.-h. Zhang, A. Marconi, L.-m. Xu, C.-x. Yang, G.-w. Sun, X.-l. Feng, C.-q. Ling, W.-z. Qin, G. Uzan, and P. d'Alessio Tripterine inhibits the expression of adhesion molecules in activated endothelial cells J. Leukoc. Biol., August 1, 2006; 80(2): 309 - 319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yozai, K. Shikata, M. Sasaki, A. Tone, S. Ohga, H. Usui, S. Okada, J. Wada, R. Nagase, D. Ogawa, et al. Methotrexate Prevents Renal Injury in Experimental Diabetic Rats via Anti-Inflammatory Actions J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3326 - 3338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Kuldo, J. Westra, S. A. Asgeirsdottir, R. J. Kok, K. Oosterhuis, M. G. Rots, J. P. Schouten, P. C. Limburg, and G. Molema Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1229 - C1239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zou, V. R. Shinde Patil, N. M. Dagia, L. A. Smith, M. J. Wargo, K. A. Interliggi, C. M. Lloyd, D. F. J. Tees, B. Walcheck, M. B. Lawrence, et al. PSGL-1 derived from human neutrophils is a high-efficiency ligand for endothelium-expressed E-selectin under flow Am J Physiol Cell Physiol, August 1, 2005; 289(2): C415 - C424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-R. Yang, S.-L. Hsieh, F.-M. Ho, and W.-W. Lin Decoy Receptor 3 Increases Monocyte Adhesion to Endothelial Cells via NF-{kappa}B-Dependent Up-Regulation of Intercellular Adhesion Molecule-1, VCAM-1, and IL-8 Expression J. Immunol., February 1, 2005; 174(3): 1647 - 1656. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
